A Tirzepatide Availability Status Update
Dear Valued Patients,
We wanted to provide an important update regarding recent FDA changes affecting certain weight-loss medications, specifically Mounjaro and Zepbound. The FDA recently removed these medications from its shortage list, and this development may impact the availability of compounded versions that many patients rely on.
While the future availability of Tirzepatide, the active ingredient in these medications, remains uncertain, we want to assure you that we are monitoring the situation closely.
We remain in regular communication with our trusted partner pharmacies to stay informed of any potential changes. In the meantime, the compounded version of Tirzepatide combined with B12 is still available. However, we want to be transparent that its availability is also uncertain as the regulatory environment continues to shift. Our goal is to minimize any disruptions to your prescriptions as much as possible, although some aspects of this situation may be outside our control.
We understand how important these medications are to your health and overall well-being, and we are committed to providing you with the support and care you deserve. Should there be any developments, we will notify you immediately and discuss any necessary adjustments or alternatives to your treatment plan.In the meantime, please feel free to reach out to us with any questions or concerns you may have.
Our team is here to help guide you through this process and ensure you continue to receive the best care possible during this time of uncertainty.
We appreciate your understanding and trust in Regenics as we navigate these changes together. Your health is always our top priority, and we are committed to doing everything we can to keep you informed and supported during this time of uncertainty.
Sincerely,
We wanted to provide an important update regarding recent FDA changes affecting certain weight-loss medications, specifically Mounjaro and Zepbound. The FDA recently removed these medications from its shortage list, and this development may impact the availability of compounded versions that many patients rely on.
While the future availability of Tirzepatide, the active ingredient in these medications, remains uncertain, we want to assure you that we are monitoring the situation closely.
We remain in regular communication with our trusted partner pharmacies to stay informed of any potential changes. In the meantime, the compounded version of Tirzepatide combined with B12 is still available. However, we want to be transparent that its availability is also uncertain as the regulatory environment continues to shift. Our goal is to minimize any disruptions to your prescriptions as much as possible, although some aspects of this situation may be outside our control.
We understand how important these medications are to your health and overall well-being, and we are committed to providing you with the support and care you deserve. Should there be any developments, we will notify you immediately and discuss any necessary adjustments or alternatives to your treatment plan.In the meantime, please feel free to reach out to us with any questions or concerns you may have.
Our team is here to help guide you through this process and ensure you continue to receive the best care possible during this time of uncertainty.
We appreciate your understanding and trust in Regenics as we navigate these changes together. Your health is always our top priority, and we are committed to doing everything we can to keep you informed and supported during this time of uncertainty.
Sincerely,
